19 May 2013
Keywords: Roche, Tarceva, Lung cancer, NSCLC, UK, NICE
Article | 10 May 2012
Having received further previously requested data from Swiss drug major Roche (ROG: SIX), the UK drugs watchdog the National Institute ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 May 2012
17 May 2013
© 2013 thepharmaletter.com